Advesya
Besançon, FR · 1 known investors
Find your way into Advesya
20 people in our graph share verified history with the Advesya team — schools, employers, funds. One of them is your warm intro.
Sean Dempseyunlockedknows André Albergaria · together at Emi Labs
×11knows the team · via Biovance Capital Partners SCR
Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).
Founders & leadership
CF
Christophe FerrandinFounder and Board Member (Director of R&D)
MD
Marina DeschampsinFounder (Director of CMC)Marina Deschamps spent over 19 years in translational immunotherapy research at the French Blood Institute (EFS), where she led gene therapy clinical trials and specialized in CAR T-cell engineering and manufacturing processes; she is now Founder and CTO of Advesya, developing cell and gene therapies for cancer and autoimmune diseases.
AB
Board
KP
Ksenija PavleticinA.I. Chief Executive OfficerGeneral Partner & Chief Commercial Officer at Jeito Capital
Investors · 1
Frequently asked questions
- What does Advesya do?
- Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).
- Who founded Advesya?
- Advesya was founded by Christophe Ferrand, Marina Deschamps, André Baruchel.
- Who are Advesya's investors?
- Advesya's investors include Jeito Capital.
- Where is Advesya headquartered?
- Advesya is headquartered in Besançon, FR.